Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1979 Dec;40(6):862–865. doi: 10.1038/bjc.1979.277

Triple hormone-receptor assay: a more accurate predictive tool for the treatment of advanced breast cancer?

D M Barnes, L G Skinner, G G Ribeiro
PMCID: PMC2010127  PMID: 230853

Abstract

In a group of 74 patients with advanced metastatic breast cancer, 57% of those with cytoplasmic oestrogen receptor activity in their tumours (REC+) showed a clinical response to endocrine therapy. Of 51 patients whose tumour was assayed for both REC and cytoplasmic progesterone (RPC) activity, 9/12 patients with REC+ RPC+ tumours responded to hormone treatment, whereas only 3/30 patients with REC-RPC-tumours had a clinical response. In a group of 19 patients in whom nuclear oestrogen receptor (REN) was also estimated in the pellets from tumour-tissue homogenates, 5/6 with tumours positive for all 3 receptors showed a clinical response. None of the 9 patients with triply negative tumours responded. Addition of the REN assay appears to reinforce the greater precision of prediction when RPC as well as REC are estimated in breast tumours.

Full text

PDF
862

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes D. M., Ribeiro G. G., Skinner L. G. Two methods for measurement of oestradiol-17 beta and progesterone receptors in human breast cancer and correlation with response treatment. Eur J Cancer. 1977 Oct;13(10):1133–1143. doi: 10.1016/0014-2964(77)90012-3. [DOI] [PubMed] [Google Scholar]
  2. Garola R. E., McGuire W. L. An improved assay for nuclear estrogen receptor in experimental and human breast cancer. Cancer Res. 1977 Sep;37(9):3333–3337. [PubMed] [Google Scholar]
  3. Horwitz K. B., McGuire W. L. Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science. 1975 Aug 29;189(4204):726–727. doi: 10.1126/science.168640. [DOI] [PubMed] [Google Scholar]
  4. Laing L., Smith M. G., Calman K. C., Smith D. C., Leake R. E. Nuclear oestrogen receptors and treatment of breast cancer. Lancet. 1977 Jul 23;2(8030):168–169. doi: 10.1016/s0140-6736(77)90183-0. [DOI] [PubMed] [Google Scholar]
  5. Leavitt W. W., Chen T. J., Allen T. C. Regulation of progesterone receptor formation by estrogen action. Ann N Y Acad Sci. 1977 Mar 11;286:210–225. doi: 10.1111/j.1749-6632.1977.tb29418.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES